These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

713 related articles for article (PubMed ID: 28035582)

  • 21. Different effects of antihypertensive drugs on endothelial dysfunction.
    Puddu P; Puddu GM; Cravero E; Muscari A
    Acta Cardiol; 2004 Oct; 59(5):555-64. PubMed ID: 15529563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of chemokines in hypertension.
    Martynowicz H; Janus A; Nowacki D; Mazur G
    Adv Clin Exp Med; 2014; 23(3):319-25. PubMed ID: 24979502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endothelial Functions.
    Godo S; Shimokawa H
    Arterioscler Thromb Vasc Biol; 2017 Sep; 37(9):e108-e114. PubMed ID: 28835487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of amlodipine and S(-)-amlodipine on vascular endothelial function in patients with hypertension.
    He Y; Si D; Yang C; Ni L; Li B; Ding M; Yang P
    Am J Hypertens; 2014 Jan; 27(1):27-31. PubMed ID: 23959544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endothelial dysfunction in inflammatory bowel diseases: Pathogenesis, assessment and implications.
    Cibor D; Domagala-Rodacka R; Rodacki T; Jurczyszyn A; Mach T; Owczarek D
    World J Gastroenterol; 2016 Jan; 22(3):1067-77. PubMed ID: 26811647
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endothelium, aging, and hypertension.
    Taddei S; Virdis A; Ghiadoni L; Versari D; Salvetti A
    Curr Hypertens Rep; 2006 Apr; 8(1):84-9. PubMed ID: 16600164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Markers of inflammation, endothelial activation, and arterial stiffness in hypertensive heart disease and the effects of treatment: results from the SILVHIA study.
    Jekell A; Malmqvist K; Wallén NH; Mörtsell D; Kahan T
    J Cardiovasc Pharmacol; 2013 Dec; 62(6):559-66. PubMed ID: 24084214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Endothelial dysfunction and arterial hypertension].
    Marecková Z; Heller S; Horký K
    Vnitr Lek; 1999 Apr; 45(4):232-7. PubMed ID: 11045186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drugs with blocking effects on the renin-angiotensin-aldosterone system do not improve endothelial dysfunction long-term in hypertensive patients.
    Sozen AB; Kayacan MS; Tansel T; Celebi A; Kudat H; Akkaya V; Erk O; Hatipoglu I; Demirel S
    J Int Med Res; 2009; 37(4):996-1002. PubMed ID: 19761681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of Xin-Ji-Er-Kang formula on 2K1C-induced hypertension and cardiovascular remodeling in rats.
    Guo K; Lan CZ; Yu TT; Huang LL; Wang XH; Pan C; Gao S
    J Ethnopharmacol; 2014 Sep; 155(2):1227-35. PubMed ID: 25063306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Endothelial function test].
    Tomiyama H
    Nihon Rinsho; 2015 Nov; 73(11):1836-40. PubMed ID: 26619655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endothelium dysfunction in the coronary circulation.
    Lüscher TF; Noll G
    J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S16-26. PubMed ID: 7700060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different effect of antihypertensive drugs on conduit artery endothelial function.
    Ghiadoni L; Magagna A; Versari D; Kardasz I; Huang Y; Taddei S; Salvetti A
    Hypertension; 2003 Jun; 41(6):1281-6. PubMed ID: 12719441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endothelial dysfunction in diabetes and hypertension: cross talk in RAS, BMP4, and ROS-dependent COX-2-derived prostanoids.
    Wong WT; Tian XY; Huang Y
    J Cardiovasc Pharmacol; 2013 Mar; 61(3):204-14. PubMed ID: 23232839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Significance of Endothelial Dysfunction in Essential Hypertension.
    Gkaliagkousi E; Gavriilaki E; Triantafyllou A; Douma S
    Curr Hypertens Rep; 2015 Nov; 17(11):85. PubMed ID: 26371063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vascular endothelium as a target of beraprost sodium and fenofibrate for antiatherosclerotic therapy in type 2 diabetes mellitus.
    Otsuki M; Goya K; Kasayama S
    Vasc Health Risk Manag; 2005; 1(3):209-15. PubMed ID: 17319106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Endothelial function and arterial hypertension].
    Taddei S; Virdis A; Ghiadoni L; Salvetti A
    Ann Ital Med Int; 1995 Oct; 10 Suppl():85S-90S. PubMed ID: 8562274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endothelium, atherosclerosis and calcium channel blockers.
    Biswas TK
    J Indian Med Assoc; 2003 Jul; 101(7):428-31. PubMed ID: 14748381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Application of coenzyme Q(10) in combination therapy of arterial hypertension].
    Mikhin VP; Kharchenko AV; Rosliakova EA; Cherniatina MA
    Kardiologiia; 2011; 51(6):26-31. PubMed ID: 21878067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hypertension and endothelial dysfunction].
    Zoghi M; Nalbantgil I
    Anadolu Kardiyol Derg; 2002 Jun; 2(2):142-7, AXVIII. PubMed ID: 12134540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.